Lipidor publishes interim report for Q1 2020
Today, Lipidor AB publishes its interim report for the period January - March 2020. The Q1 report is available on the company's website lipidor.se and in the attached pdf.Summary of the interim report – first quarter 2020 Positive results from the Phase III study of AKP01 validate AKVANO®, the company's patented lipid-based technology. Lipidor has prepared the Phase III study of AKP02. The planned study is fully self-financed from the company’s existing funds. The launch of Skin Disinfection Spray in collaboration with Aurena Laboratories creates cash flow.